Atlas Trials

Metabolic Sodium MRI to Assess Early Response of Breast Cancer to Neoadjuvant Chemotherapy

Clinical trial NCT03750240 · TERMINATED

Trial details

NCT number
NCT03750240
Sponsor
NYU Langone Health
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast CancerTriple Negative Breast Cancer
Start date
2017-07-25
Primary completion
2021-06-24
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.